Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex

International Journal of Neuropsychopharmacology

Volumn 17, Issue 8, 2014, Pages 1321-1326

  Nishitani, Naoya ^a   Nagayasu, Kazuki ^a,b   Asaoka, Nozomi ^a   Yamashiro, Mayumi ^a   Shirakawa, Hisashi ^a   Nakagawa, Takayuki ^a,c   Kaneko, Shuji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

AMPA receptors; Dorsal raphe nucleus; Ketamine; Serotonin; 4< inf> 2< inf> nicotinic acetylcholine receptors

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; CYCLOTHIAZIDE; DIHYDRO BETA ERYTHROIDINE; KETAMINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RIVANICLINE; SEROTONIN; AMPA RECEPTOR ANTAGONIST; 1-NAPHTHYLACETYLSPERMINE; 2,3-DIOXO-6-NITRO-7-SULFAMOYLBENZO(F)QUINOXALINE; ANTIDEPRESSANT AGENT; BENZOTHIADIAZINE DERIVATIVE; NICOTINIC RECEPTOR ALPHA4BETA2; QUINOXALINE DERIVATIVE; SPERMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG EFFICACY; IN VIVO STUDY; INTERNEURON; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; AREA UNDER THE CURVE; CONCENTRATION (PARAMETERS); DRUG EFFECT; MICRODIALYSIS; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; MICROINJECTION; SECRETION (PROCESS); SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BENZOTHIADIAZINES; DIHYDRO-BETA-ERYTHROIDINE; DORSAL RAPHE NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, SUBCUTANEOUS; KETAMINE; MALE; MICRODIALYSIS; MICROINJECTIONS; NICOTINIC ANTAGONISTS; PREFRONTAL CORTEX; QUINOXALINES; RATS; RECEPTORS, AMPA; RECEPTORS, NICOTINIC; SEROTONIN; SPERMINE;

EID: 84927565759     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145714000649     Document Type: Article

References (25)

1. Amargos-Bosch M, Lopez-Gil X, Artigas F, Adell A (2006) Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine. Int J Neuropsychopharmacol 9:565-573.
2. Amargos-Bosch M, Adell A, Artigas F (2007) Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex. J Neurochem 102:550-561.
3. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, Kavalali ET, Monteggia LM (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475:91-95.
4. Belmaker RH, Agam G (2008) Major depressive disorder. N Engl J Med 358:55-68.
5. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351-354.
6. Boothman L, Raley J, Denk F, Hirani E, Sharp T (2006) In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Br J Pharmacol 149:861-869.
7. Challis C, Boulden J, Veerakumar A, Espallergues J, Vassoler FM, Pierce RC, Beck SG, Berton O (2013) Raphe GABAergic neurons mediate the acquisition of avoidance after social defeat. J Neurosci 33:13978-13988.
8. Chang B, Daniele CA, Gallagher K, Madonia M, Mitchum RD, Barrett L, Vezina P, McGehee DS (2011) Nicotinic excitation of serotonergic projections from dorsal raphe to the nucleus accumbens. J Neurophysiol 106:801-808.
9. Duman RS, Voleti B (2012) Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci 35:47-56.
10. Gardier AM, Malagié I, Trillat AC, Jacquot C, Artigas F (1996) Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam Clin Pharmacol 10:16-27.
11. Garduno J, Galindo-Charles L, Jimenez-Rodriguez J, Galarraga E, Tapia D, Mihailescu S, Hernandez-Lopez S (2012) Presynaptic a4ß2 nicotinic acetylcholine receptors increase glutamate release and serotonin neuron excitability in the dorsal raphe nucleus. J Neurosci 32:15148-15157.
12. Gartside SE, Cole AJ, Williams AP, McQuade R, Judge SJ (2007) AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei. Eur J Neurosci 25:3001-3008.
13. Gigliucci V, O'Dowd G, Casey S, Egan D, Gibney S, Harkin A (2013) Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism. Psychopharmacology (Berl) 228:157-166.
14. Homayoun H, Moghaddam B (2007) NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27:11496-11500.
15. Kim SH, Price MT, Olney JW, Farber NB (1999) Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists. Mol Psychiatry 4:344-352.
16. Lopez-Gil X, Jimenez-Sanchez L, Romon T, Campa L, Artigas F, Adell A (2012) Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists. Int J Neuropsychopharmacol 15:945-956.
17. Maeng S, Zarate CA Jr., Du J, Schloesser RJ, McCammon J, Chen G, Manji HK (2008) Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63:349-352.
18. McCardle CE, Gartside SE (2012) Effects of general anaesthetics on 5-HT neuronal activity in the dorsal raphe nucleus. Neuropharmacology 62:1787-1796.
19. McGehee DS, Heath MJ, Gelber S, Devay P, Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:1692-1696.
20. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927.
21. Nagayasu K, Yatani Y, Kitaichi M, Kitagawa Y, Shirakawa H, Nakagawa T, Kaneko S (2010) Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release. Br J Pharmacol 161:1527-1541.
22. Nelson CL, Burk JA, Bruno JP, Sarter M (2002) Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats. Psychopharmacology (Berl) 161:168-179.
23. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edn. Waltham: Academic Press.
24. Woolf NJ, Butcher LL (1989) Cholinergic systems in the rat brain: IV. Descending projections of the pontomesencephalic tegmentum. Brain Res Bull 23:519-540.
25. Yang C, Hu YM, Zhou ZQ, Zhang GF, Yang JJ (2013) Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test. Ups J Med Sci 118:3-8.